VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 69 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,106,758 | -32.6% | 2,465,388 | -0.5% | 0.00% | 0.0% |
Q2 2023 | $28,366,231 | +346.6% | 2,477,400 | +200.7% | 0.00% | – |
Q1 2023 | $6,351,397 | +23.5% | 823,787 | -2.3% | 0.00% | – |
Q4 2022 | $5,141,837 | +47.1% | 842,924 | +42.7% | 0.00% | – |
Q3 2022 | $3,496,000 | +4.9% | 590,504 | +4.7% | 0.00% | – |
Q2 2022 | $3,334,000 | -14.9% | 564,215 | +9.7% | 0.00% | – |
Q1 2022 | $3,919,000 | +211.0% | 514,155 | +10.6% | 0.00% | – |
Q4 2021 | $1,260,000 | -48.5% | 464,836 | -50.1% | 0.00% | – |
Q3 2021 | $2,447,000 | -37.1% | 930,735 | -1.3% | 0.00% | – |
Q2 2021 | $3,893,000 | -67.2% | 942,666 | -62.6% | 0.00% | – |
Q1 2021 | $11,882,000 | -34.3% | 2,522,420 | -0.3% | 0.00% | -100.0% |
Q4 2020 | $18,088,000 | -34.2% | 2,529,731 | -1.8% | 0.00% | 0.0% |
Q3 2020 | $27,476,000 | -17.2% | 2,575,103 | -2.0% | 0.00% | 0.0% |
Q2 2020 | $33,175,000 | +50.6% | 2,628,767 | +9.2% | 0.00% | 0.0% |
Q1 2020 | $22,029,000 | -25.4% | 2,407,352 | +13.7% | 0.00% | 0.0% |
Q4 2019 | $29,535,000 | -19.3% | 2,117,194 | -0.5% | 0.00% | -50.0% |
Q3 2019 | $36,607,000 | -35.3% | 2,127,104 | +2.3% | 0.00% | 0.0% |
Q2 2019 | $56,605,000 | +56.1% | 2,079,554 | +9.8% | 0.00% | 0.0% |
Q1 2019 | $36,251,000 | +107.4% | 1,893,972 | +1.9% | 0.00% | +100.0% |
Q4 2018 | $17,477,000 | -50.4% | 1,859,018 | -0.3% | 0.00% | -50.0% |
Q3 2018 | $35,262,000 | -2.2% | 1,863,766 | +1.0% | 0.00% | 0.0% |
Q2 2018 | $36,066,000 | +33.5% | 1,845,706 | +28.3% | 0.00% | +100.0% |
Q1 2018 | $27,020,000 | +34.4% | 1,438,029 | +18.8% | 0.00% | 0.0% |
Q4 2017 | $20,099,000 | +40.2% | 1,210,763 | +73.9% | 0.00% | 0.0% |
Q3 2017 | $14,339,000 | +139.4% | 696,418 | +4.2% | 0.00% | – |
Q2 2017 | $5,990,000 | -15.6% | 668,433 | +24.8% | 0.00% | – |
Q1 2017 | $7,094,000 | +13542.3% | 535,727 | +12966.5% | 0.00% | – |
Q4 2016 | $52,000 | -26.8% | 4,100 | -30.8% | 0.00% | – |
Q3 2016 | $71,000 | +9.2% | 5,927 | 0.0% | 0.00% | – |
Q2 2016 | $65,000 | +6400.0% | 5,927 | +6635.2% | 0.00% | – |
Q1 2016 | $1,000 | – | 88 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 7,891,176 | $154,194,000 | 51.35% |
Trustees of Princeton University | 203,638 | $3,979,000 | 4.13% |
Casdin Capital, LLC | 1,135,000 | $22,178,000 | 3.10% |
GREAT POINT PARTNERS LLC | 730,010 | $14,264,000 | 1.98% |
BB BIOTECH AG | 2,532,641 | $49,488,000 | 1.43% |
Aevitas Wealth Management, Inc. | 73,323 | $1,433,000 | 1.40% |
Patriot Financial Group Insurance Agency, LLC | 64,256 | $1,256,000 | 1.34% |
Virtus ETF Advisers LLC | 37,502 | $733,000 | 0.65% |
Eventide Asset Management | 703,425 | $13,745,000 | 0.57% |
THOMPSON DAVIS & CO., INC. | 11,951 | $234,000 | 0.56% |